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Copyright © 2005 by The American Asso-
ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2004.09.003Objective: Fetal cardiac surgery has potential benefits for treatment of some con-
genital heart defects. However, placental dysfunction as a result of fetal bypass, fetal
stress, and fetal exposure to external milieu needs to be overcome to optimize the
outcomes of fetal cardiac bypass. In this study we evaluated the technical feasibility
of cardiac bypass in the nonhuman primate fetus and the efficacy of different
anesthetic approaches.
Methods: Twelve baboon fetuses, average gestation 146  8 days and weight 696 
184 g, were used. Three fetuses were excluded from the study because of nuchal cord
presentations. The animals were separated into two anesthesia groups: isoflurane (n 
6) and fentanyl and midazolam (n  3). A miniature roller pump circuit without
oxygenator was used for fetal bypass for 30 minutes. No blood transfusion was
performed. Fetal blood gas samples were collected before bypass, during bypass, and at
15 and 60 minutes after bypass.
Results: All fetuses in the isoflurane group were successfully placed on the cardiac
bypass circuit. However, 2 animals in the fentanyl and midazolam group were not
placed on the bypass circuit because of sustained elevation in maternal uterine tone.
All maternal baboons survived. Of the 6 fetuses in the isoflurane group, 5 survived
for 60 minutes; however, placental function continued to deteriorate after bypass
(PaO2 33  3 mm Hg before bypass, 23  6 mm Hg 15 minutes after, and 18  9
mm Hg 60 minutes after).
Conclusion: The technical feasibility of cardiac bypass in nonhuman primate fetuses
weighing less than 1000 g was confirmed. Isoflurane anesthesia appears to be
superior to fentanyl and midazolam anesthesia for fetal cardiac surgery because of
adequate uterine relaxation.
Fetal cardiac surgery is a challenging innovation for treatment ofcomplex cardiac anomalies that start out as relatively simple lesionsearly during gestation.1 Intracardiac operations, however, require thatthe fetus be placed on extracorporeal circulation. We have success-fully achieved good fetal survival after fetal cardiac bypass in thelamb model by using an innovative bypass circuit and minimizing
fetal exposure.2,3 However, placental dysfunction caused by both hemodynamic
factors and generalized fetal stress in the procedure induces fetal morbidity that
restricts the success of this surgical procedure.1,4-8 In our previous reports,2,3,9,10 we
explored the use of continuous ketamine infusion for anesthesia in our attempt to
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Ddevelop fetal cardiac bypass techniques. However, it is well
known that ketamine does not suppress the catecholamine
release that contributes to the fetal stress response. Because
fetal lambs apparently do not possess central nerve system
narcotic receptors, the sheep is not a suitable animal model
for investigation of the efficacy of clinically relevant nar-
cotic anesthesia. We therefore have taken the next step
toward the ultimate goal of achieving human fetal intracar-
diac surgery by exploring techniques for safe and effective
fetal cardiac bypass in a nonhuman primate model. Fetal
blood volume is a critical parameter in cardiac bypass, and
the fetal baboon size (and thus blood volume) more closely
approximates that of human beings than do fetal blood
volumes of other available species. Currently isoflurane is
the most popular anesthetic agent for fetal surgery because
of the desirable side effect of uterine relaxation11,12 and its
simple and reliable delivery by maternal inhalation. Fenta-
nyl is a proven effective anesthetic agent for suppression of
surgical stress in neonatal cardiac surgery. In this study we
evaluated the response of the nonhuman primate fetus to
cardiac bypass, comparing the efficacies of isoflurane and
fentanyl anesthesia.
Methods
A total of twelve baboon fetuses, average gestation 146  8 days
(80% gestation) and weight 696 184 g, were used. The maternal
baboon fasted for 8 hours. After premedication of the animal with
ketamine (10 mg/kg) and atropine (0.04 mg/kg) by intramuscular
TABLE 1. Fetal and maternal baboon data, including preby
Anesthetic
method
Maternal
Weight (kg) pH PaCO2 PaO2
1 Isoflurane 14.3 7.43 38 538
2 Isoflurane 14 7.5 33 480
3 Isoflurane 14.2 7.38 41 247
4 Isoflurane 17 7.47 32 466
5 Isoflurane 15.8 7.46 27 350
6 Isoflurane 16.3 7.46 34 452
1-6
Mean 15.3 7.45 34 422
SD 1.2 0.04 4 96
7 Fentanyl and
midazolam
15.2 7.51 27 505
8 Fentanyl and
midazolam
19.3 7.48 30 484
9 Fentanyl and
midazolam
17.4 7.43 30 618
7-9
Mean 17.3 7.47 29 536
SD 2.1 0.04 2 72
*P  .02 versus isoflurane group.
†P  .025 versus isoflurane group.injection, peripheral intravenous access and an intra-arterial mon-
176 The Journal of Thoracic and Cardiovascular Surgery ● Januitoring catheter were established, and lactated Ringer solution was
administered intravenously.
The baboon was placed in the supine position on a warming
blanket. Oxygen at 100% was administered, and the heart rate and
oxygen saturation were continuously monitored by pulse oximetry.
After the induction of anesthesia, the baboon was intubated and
ventilated with 100% oxygen and volume-control to maintain
PaCO2 in a physiologic range.
Anesthetic and Surgical Protocols
The animals were separated into the isoflurane (n  6) and
fentanyl and midazolam (n  3) groups. Three fetuses were
excluded from the study because of nuchal cord presentations.
All subjects were initially anesthetized with 1% to 2%
isoflurane. In the isoflurane group, vapor anesthesia was con-
tinued without interruption. Once intravenous access to the
fetus had been obtained, the anesthesia modality was switched
for the fentanyl and midazolam group. In this group, anesthesia
was induced individually for mother and fetus by infusion of
fentanyl at 50 g/kg and midazolam at 0.1 mg/kg and main-
tained with continuous infusion of fentanyl at 10 g/(kg · h) and
midazolam at 0.1 mg/(kg · h). Total dose of fentanyl given for
maternal baboon was 76  31 g/kg.
After laparotomy, a low transverse hysterotomy was made,
taking care to avoid the placenta. In the initial few studies, the
fetuses were totally exteriorized from the uterus, and the fetal head
was enclosed in a surgical glove containing warm saline solution
to prevent air breathing. In the later two studies, the fetus was only
partially exteriorized. In the fentanyl and midazolam group, a
peripheral intravenous line was established in the partially exteri-
s arterial blood gas values, and outcomes
Fetal
Outcomeeight (g) pH PaCO2 PaO2
603 7.32 46.1 38 Observed for 2 h postbypass
780 7.33 53 31
490 7.29 58 31
1000 7.32 49 31
672 7.34 39 34
585 7.32 49 31 Die 20 min postbypass
688 7.32 49 33
165 0.02 6 3
474 7.09 47 21 Failed to go on bypass
938 7.08 61 16 Died after bypass
727 7.12 82 15 Failed to go on bypass
713 7.10* 63 17†
232 0.02 18 3pas
Worized extremity for administration of drugs. Fetal sternotomy and
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Dpericardiotomy were performed. A 22-gauge arterial catheter was
inserted in the carotid artery. Purse-string sutures were placed on
the main pulmonary artery and the right atrium with 5-0 polypro-
pylene sutures (Ethicon, Inc, Somerville, NJ). A 300-U/kg dose of
heparin was given intravenously to the fetus through the right
atrium. The right atrium was cannulated with a 10F ventricular
vent cannula (Medtronic DLP, Grand Rapids, Mich). A 14- or
16-gauge angiocatheter was placed in the main pulmonary artery
as an arterial cannula. Both arterial and venous cannulas were
connected to the bypass circuit, which was filled with 14 to 20 mL
Figure 1. Changes in fetal arterial blood gas values with cardiac
bypass in isoflurane group: pH (A), PaCO2 (B), and PaO2 (C). Each
line indicates values for individual fetus. Solid line indicates
fetus (case 1) in which placental dysfunction was suppressed.crystalloid solution (Normosol-R; Abbott Laboratories, Abbott
The Journal of ThoraciPark, Ill). No oxygenator was used in the circuit. Pump flows were
continuously monitored with an inline ultrasonic flow probe (Tran-
sonic Systems, Inc, Ithaca, NY). Maximum achievable pump flow
was maintained in each animal (176  70 mL/[min · kg]). Fetuses
were infused at 50 mL/(kg · h) with crystalloid solution during
bypass to maintain adequate bypass flow and hemodynamics. The
fetus was placed on normothermic cardiac bypass for 30 minutes.
Cardiac bypass was then discontinued. Heparin was reversed with
protamine (1 mg/kg intravenously). The fetus was then monitored
for 60 to 120 minutes outside the uterus. No fetus received blood
transfusions throughout the study to eliminate any potential ad-
verse effects of adult hemoglobin. Subsequently, the fetus was
killed with intravenous pentobarbital sodium (150 mg/kg) and a
fetectomy was performed. Oxytocin (10 IU) was administered to
effect delivery of the placenta and prevent continuous bleeding
from the uterus.
The hysterotomy and the laparotomy were closed in the usual
surgical manner. Cefazolin (15 mg/kg intravenously) was admin-
istered after the operation. After full recovery from anesthesia, the
Figure 2. Changes in serum concentration of epinephrine with
cardiac bypass in isoflurane group. Each line indicates values for
individual fetus. Solid line indicates fetus (case 1) in which
placental dysfunction was suppressed.
Figure 3. Changes in hematocrit with cardiac bypass in isoflu-
rane group. Each line indicates values for individual fetus. Solid
line indicates fetus (case 1) in which placental dysfunction was
suppressed.baboon was extubated and received standard postoperative care.
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Hemodynamic variables were continuously recorded during the
entire study. Maternal blood gas values were measured every
30 minutes. Fetal blood gas values were measured before by-
pass, 15 minutes into bypass, and at 15 and 60 minutes after
bypass. Blood gas values, pH, and hematocrit were measured
with a clinical blood gas analyzer (International Technidyne
Corp, Andover, Mass). As an indicator of fetal stress, serum
epinephrine concentration was measured at the same time point
as blood gas values. Blood samples (1 mL) were drawn through
the arterial catheter, placed immediately in a serum tube with
separation gel, mixed gently five times in tube, then centrifuged
at 2000 rpm for 10 minutes at 4°C and stored at 4°C until
off-site assay (IDEXX Laboratories, Sunnyvale, Calif).
All animals received humane care in compliance with the
“Principles of Laboratory Animal Care” formulated by the Na-
tional Society of Medical Research and the “Guide for the Care
and Use of Laboratory Animals” (http://www.nap.edu/catalog/
5140.html). The experimental protocol was approved by the Insti-
tutional Animal Care and Use Committees at the University of
California San Francisco and Stanford University.
Statistical Methods
All values are expressed as mean  SD. The Mann-Whitney test
was used in comparing the isoflurane group with the fentanyl and
midazolam group. The Wilcoxon signed rank test was used to
compare the change in blood gas and hemodynamic values before,
during, and after cardiac bypass.
Results
Maternal heart rate, blood pressure, and prebypass blood
gas values were normal, and there were no differences
between the two anesthetic groups (data not shown). In the
fentanyl and midazolam group, however, prebypass fetal
arterial blood gas parameters significantly deteriorated rel-
ative to the isoflurane group (Table 1). Moreover, all fetuses
in the isoflurane group were placed on cardiac bypass;
however, only 1 fetus in the fentanyl and midazolam group
could be placed on cardiac bypass. The other two fetuses
could not be placed on cardiac bypass because of poor blood
gas status, which was probably caused by high uterine tone.
One fetus in the isoflurane group died 20 minutes into
bypass.
Blood Gas Analysis
Figure 1 demonstrates the change in blood gas parameters.
PaO2 decreased steadily after initiation of cardiac bypass to
the end of the observation period. PaCO2 was well main-
tained during cardiac bypass; however, it was increased
after bypass, especially at 60 minutes after cessation of
bypass. One fetus (case 1) maintained good respiratory
function at 60 minutes after the bypass. The blood gas data
of this fetus 2 hours after bypass was as follows: pH 7.25,
PaCO2 62.5 mm Hg, and PaO2 19.2 mm Hg.
178 The Journal of Thoracic and Cardiovascular Surgery ● JanuEpinephrine Concentration
Figure 2 demonstrates the change in serum concentration of
epinephrine with bypass. During the entire experiment, the
level of epinephrine was increased above the upper range of
normal level. Interestingly, the fetus that maintained normal
blood gas parameters and high hematocrit (case 1) also
maintained low levels (0.03 ng/mL) of epinephrine, and the
level was maintained as long as 2 hours after bypass.
Hemodilution
Figure 3 shows the changes in hematocrit with bypass.
Preoperative hematocrit was 40%  5%. After initiation of
bypass, hematocrit was significantly decreased to 21% 
7% (P  .027 vs prebypass) as a result of hemodilution and
surgical blood loss. After discontinuation of bypass, hemat-
ocrit was further decreased to 18%  5% in 15 minutes.
One fetus (case 1) lost less blood at the initiation of bypass
and maintained a high hematocrit after bypass.
Fetal Blood Pressure
Figure 4 shows the change in mean systemic arterial blood
pressure with bypass. Prebypass mean arterial blood pres-
sure was 31 6 mm Hg. After initiation and during bypass,
mean arterial blood pressure was maintained; however, it
decreased after bypass. The 1 fetus that maintained the pre
bypass level of mean arterial blood pressure after cessation
of bypass (case 1) also had high hematocrit.
Discussion
In this study we confirmed that fetal tissue has enough
tensile strength to allow instrumentation for cardiac bypass.
Furthermore, our experience has provided additional insight
into some of the critical variables necessary for the future
advancement of fetal cardiac surgical intervention.
Maximizing survival after fetal cardiac surgery requires
Figure 4. Changes in mean systemic arterial blood pressure with
cardiac bypass in isoflurane group. Each line indicates values for
individual fetus. Solid line indicates fetus (case 1) in which
placental dysfunction was suppressed.not only technical expertise but also minimization of the
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sion, and prevention of placental dysfunction. In earlier
ovine fetal studies, continuous ketamine infusion was used
as an anesthetic agent.2,3,6,9,10 However, ketamine does not
block the release of catecholamine in response to stress.
High doses of the narcotic fentanyl provide effective anes-
thesia in neonates and infants undergoing cardiac proce-
dures with respect to both blockage of the stress response
and maintenance of cardiac function. To evaluate the effi-
cacy of this agent, we administered a combination of fent-
anyl and midazolam to the mother and fetus individually.
However, the combination of these drugs did not provide
enough uterine relaxation to prevent the induction of fetal
distress from hypoxia before the institution of cardiac by-
pass. Thus technical factors arose due to lack of adequate
fetal exposure. On the other hand, isoflurane is preferred for
use in fetal noncardiac surgery because of its uterine mus-
cle–relaxing properties and ease of administration.11,12 In
our experiments, uterine tone was well managed for fetal
manipulation, including exteriorization from and reposition-
ing into the uterus, in the isoflurane group. Isoflurane ap-
pears to be quite suitable as an anesthetic agent for fetal
cardiac surgery. We have previously reported that placental
vasoconstriction in response to endothelin was augmented
after fetal cardiac bypass.9 Both ketamine and isoflurane can
cross the placenta rapidly.13,14 In an in vitro study, Boillot
and colleagues15 reported that isoflurane exerts an indo-
methacin-like effect on the production of an endothelially
derived vasoconstricting cyclooxygenase product, as dem-
onstrated by the reduction in the endothelin 1–induced
vascular contraction of isolated rat aorta. On the other hand,
clinical doses of ketamine have been found not to affect
vasoconstriction in porcine cerebral artery.16 These data
also support the concept that isoflurane anesthesia is bene-
ficial not only for fetal manipulation in the uterus but also
for a possible reduction in placental dysfunction through
suppression of eicosanoid mediators of vasoconstriction.
However, isoflurane has been reported to depress fetal car-
diac function.13 In our study, isoflurane did not seem to
suppress fetal stress, as evidenced by the increase in serum
fetal epinephrine levels. Although we are not aware of
studies of long-term survival after fetal cardiac surgery with
isoflurane, our experience suggests that the combination of
inhalation of low concentration of isoflurane for mother and
administration of fentanyl directly to the fetus might be a
better combination in fetal cardiac surgery than either agent
alone in both mother and fetus. Another alternative is a
narcotic in combination with administration of nitric oxide
donor to control uterine relaxation and to avoid the effect of
isoflurane on the fetus. This combination may well strike the
most beneficial balance of inhibition of fetal stress, uterine
relaxation, and preservation of fetal myocardial function.
The Journal of ThoraciFurther studies are needed to determine the most suitable
anesthetic regimen for fetal cardiac bypass surgery.
Placental dysfunction after fetal cardiac bypass is a ma-
jor obstacle to good long-term outcome.4,6,7,9 In our study,
we generally could not prevent deterioration of placental
gas exchange and hemodynamics even in the isoflurane
group, with the exception of 1 fetus. After initiation of
cardiac bypass, PaO2 was decreased, whereas PaCO2 and
mean arterial blood pressure were maintained. We speculate
that the acute change in PaO2 after initiation of bypass may
result in part from acute hemodilution, because placental
dysfunction was characterized by elevation of fetal PaCO2,
indicating a decrease in placental blood flow.1,6 The dete-
rioration in blood gas parameters was probably caused by a
combination of several factors including reduced placental
blood flow and reduced gas exchange in placental micro-
vasculature. Indomethacin,8 high-dose steroid,6 and high
spinal anesthesia4 have been reported as useful methods to
preserve placental function in fetal cardiac bypass with
ketamine anesthesia. All those studies used transfused blood
for the circuit and neck cannulation with minimal fetal
exposure. Although we did not use either of these ap-
proaches in our studies, 1 fetus maintained good placental
function with no support methods. Comparing that fetus
with other fetuses, the most different data parameter was the
drastic change in hematocrit during the study. All fetuses
needed continuous infusion of crystalloid during bypass to
maintain adequate bypass flow and hemodynamics. Admin-
istration of crystalloid solution could probably not maintain
colloidal osmotic pressure, and the infused solution was
shifted to third space as edema. That edema probably con-
tributed to the rise in placental vascular resistance through a
“Starling resistor” mechanism.17 In future studies, the mea-
surement of wet/dry weight ratios of fetus and placenta
might be helpful to confirm this mechanism.
We have recently reported the successful treatment for
complex cardiac disease of premature infants weighing less
than 1500 g,18 demonstrating the feasibility of instrumen-
tation for human fetal cardiac bypass. In a recent case of
human fetal cardiac surgery with narcotic anesthesia, we
successfully reduced uterine tone through infusion of the
nitric oxide donor nitroglycerin (unpublished data). In both
these settings, blood transfusion was necessary to maintain
adequate bypass flows without significant hemodilution.
Despite minimal blood loss and low pump priming volume,
blood supplementation may be necessary in at least some
fetal cardiac bypass cases because of the low blood volume
(often less than 50 mL) of the fetus. Because fetal hemo-
globin exhibits a higher average affinity for oxygen than
does adult hemoglobin, the adult hemoglobin level might
have to be kept higher than prebypass hemoglobin level.
Further studies are needed to establish optimal perioperative
management in fetal cardiac surgery.
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maintenance of fetal gas exchange. In our studies, we ob-
tained a maximum flow of 176 70 mL/(kg · min) by using
a 10F venous cannula and 14- or 16-gauge arterial cannula.
The fetus was ejecting, contributing to rest of the cardiac
output. The main reason for flow limitation in those exper-
iments may simply be the size of fetus and the limited blood
volume. In this study, moreover, we used a closed circuit
without a reservoir to reduce priming volume and the total
surface area of artificial material to prevent activation of
inflammatory response. This circuit design presents a dis-
advantage for obtaining high pump flows, because the ve-
nous cannula sucks in the atrial wall easily. Therefore blood
transfusion to the fetus, instead of only crystalloid admin-
istration, and the addition of a very small venous reservoir
may be needed for safer bypass.
We have previously reported the efficacy of an inline
axial flow pump in fetal cardiac bypass with a miniaturized
circuit priming volume in both acute and long-term survival
models.2,3,10 In our baboon studies, we did not use the axial
flow pump because its minimal flow rate is too high for the
circuit used in less than a 1-kg fetus. In this study, even
though we minimized the priming volume of the bypass
circuit, we could not preserve satisfactory placental function
except for 1 animal. Perhaps hemodilution and the third
spacing of fluid were significant contributing factors to fetal
hypoxia. In addition, flow hemodynamics or mechanical
stimuli induced by an axial-flow pump may produce less
activation of vasoconstriction cascades during bypass than
seen with a roller pump. We look forward to the develop-
ment of improved axial flow pumps or assist devices that
better meet the specific needs of fetal cardiac surgery.
In this study, we confirmed the technical feasibility of
fetal cardiac bypass in a small nonhuman primate fetus.
Isoflurane anesthesia was superior to narcotic anesthesia in
that it provided sustained uterine muscle relaxation. Placen-
tal dysfunction was generally not prevented in this study,
and we attribute this largely to hemodilution. Although we
could place the fetus on the cardiac bypass, further experi-
mental evaluation including transfusion, anesthetic meth-
ods, and fetal exposure will be necessary to move forward
to clinical use of this challenging surgical intervention.
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Discussion
Dr W. Randolph Chitwood, Jr (Greenville, NC). Tell us what
you think the clinical application may be. Because this is a
primate study it should have a significant clinical application.
What are you planning to do from here on as far as other work
in this area?
Dr Ikai. The goal of fetal cardiac surgery research is ultimately
to safely intervene in utero for certain cardiac defects. The lesion
for which intervention is contemplated, such as pulmonary atresia,
should generally be a simple defect with severe secondary mor-
phologic conversions. For instance, in pulmonary valve atresia
enlargement of the right ventricle outflow tract may prevent hyp-
oplasia of the right ventricle. Similarly, severe tricuspid regurgi-
tation may result in hydrops, severe cardiomegaly, and hypoplasia
of the lungs. These problems could be prevented by tricuspid
repair in utero. We believe that other lesions, such as left ventric-
ular outflow tract obstruction, restrictive patent foramen ovale,
absent pulmonary valve with enlargement of pulmonary arteries,
hypoplastic pulmonary arteries with major aortopulmonary collat-
erals, and so on could benefit from fetal intervention.
Dr Frank A. Pigula (Boston, Mass). It’s fairly well known that
a major obstacle to fetal bypass is placental dysfunction. Did you
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you find increases in placental vascular resistance or other markers
of placental dysfunction?
Dr Ikai. We have extensively studied placental blood flow and
placental vascular resistance in an ovine model. We have evaluated
the benefits of indomethacin, steroids, and endothelin blockers onThe Journal of Thoracibaboon model, however, the goal was to study different anesthetics
and their overall effects on fetal hemodynamics, blood gas values,
and stress response.
Dr Pigula. Did you use those agents?
Dr Ikai. No, we did not. Because we wanted primarily to see
the effects of anesthesia on fetal stress and fetal blood gas values,CH
Dplacental blood flow and placental vascular reactivity. In this we did not use any other agents.c and Cardiovascular Surgery ● Volume 129, Number 1 181
